Apellis Pharmaceuticals, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 268.3M | 199.9M | 458.6M | 178.5M | 166.8M | 212.5M | 196.8M | 199.7M |
| Cost of Goods Sold | 40.8M | 29.7M | 24.5M | 14.1M | 34.4M | 40.9M | 33.6M | 23.5M |
| Gross Profit | 227.5M | 170.2M | 434.0M | 164.4M | 132.4M | 171.7M | 163.3M | 176.1M |
| R&D Expenses | 77.0M | 74.2M | 68.2M | 67.0M | 86.4M | 76.4M | 88.6M | 77.9M |
| Operating Expenses | 201.3M | 221.3M | 210.9M | 197.7M | 215.8M | 197.8M | 210.6M | 205.6M |
| Operating Income | 26.5M | -51.1M | 223.2M | -33.3M | -83.3M | -26.2M | -47.3M | -29.4M |
| Other Income / Gains | -7.3M | -7.5M | -6.9M | -8.4M | -8.6M | -9.9M | -9.6M | -8.1M |
| Net Income | 18.7M | -59.0M | 215.7M | -42.2M | -92.2M | -36.4M | -57.4M | -37.7M |
| EPS (Diluted) | 0.15 | -0.47 | 1.71 | -0.33 | -0.74 | -0.29 | -0.46 | -0.30 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.848 | 0.851 | 0.947 | 0.921 | 0.794 | 0.808 | 0.83 | 0.882 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 38.2M | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 83.3M | 0 | 0 |
| Selling General And Administrative Expenses | 124.3M | 147.1M | 142.7M | 130.7M | 129.3M | 121.5M | 122.0M | 127.6M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 241.8M | 251.1M | 235.4M | 211.8M | 250.1M | 238.7M | 244.1M | 229.1M |
| Interest Income | 2.9M | 3.5M | 4.4M | 2.6M | 2.7M | 3.4M | 2.9M | 3.2M |
| Interest Expense | 10.3M | 10.8M | 11.3M | 11.2M | 11.0M | 11.5M | 12.5M | 9.4M |
| Depreciation And Amortization | 291K | 327K | 339K | 446K | 446K | 447K | 457K | 449K |
| Ebitda | 26.8M | -47.5M | 227.9M | -30.1M | -80.4M | -24.1M | -43.9M | -27.7M |
| Ebitdaratio | 0.10 | -0.237 | 0.497 | -0.169 | -0.482 | -0.113 | -0.223 | -0.139 |
| Operating Income Ratio | 0.099 | -0.256 | 0.487 | -0.186 | -0.50 | -0.123 | -0.24 | -0.147 |
| Income Before Tax | 19.2M | -58.6M | 216.3M | -41.7M | -91.9M | -36.1M | -56.9M | -37.5M |
| Income Before Tax Ratio | 0.071 | -0.293 | 0.472 | -0.234 | -0.551 | -0.17 | -0.289 | -0.188 |
| Income Tax Expense | 496K | 313K | 602K | 466K | 341K | 286K | 592K | 114K |
| Net Income Ratio | 0.07 | -0.295 | 0.47 | -0.236 | -0.553 | -0.171 | -0.292 | -0.189 |
| Epsdiluted | 0.15 | -0.47 | 1.71 | -0.33 | -0.74 | -0.29 | -0.46 | -0.30 |
| Weighted Average Shs Out | 126.0M | 126.0M | 126.0M | 126.0M | 125.5M | 123.9M | 123.9M | 123.9M |
| Weighted Average Shs Out Dil | 126.0M | 126.0M | 126.0M | 126.0M | 125.5M | 123.9M | 123.9M | 123.9M |